A S X A N N O U N C E M E N T 9 N o v e m b e r 2 0 2 6 Vectus appoints Professor Tamera Corte as Chief Clinical Advisor HIGHLIGHTS • Professor Tamera Corte appointed as Chief Clinical Advisor, bringing extensive expertise in pulmonary fibrosis and clinical trial development. • Professor Corte...
Appointment of Prof Tamera Corte as Chief Clinical Advisor
Filed with ASX · · 2 pages · English
Release
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Notification regarding unquoted securities - VBS
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Results of 2026 AGM
- 2026 AGM Presentations
- FDA Pre-IND Meeting Request Granted for VB0004
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems